Intrinsic Value of S&P & Nasdaq Contact Us

Fulgent Genetics, Inc. FLGT NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
47/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$36.00
+122.6%

Stock Statistics — FLGT

Fulgent Genetics, Inc. (FLGT) has a market capitalization of $505M and trades at $16.17. The 52-week range is 13.46-31.04.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.2, Earnings Per Share (EPS) of $-1.97, annual revenue of $322.67M.

The stock has a beta of 0.89, operates in the Healthcare sector.

Trading Data
Current Price$16.17
52-Week Range13.46-31.04
Volume430.84K
Avg Volume (30D)532.93K
Market Cap$505M
Beta (1Y)0.89
Company
IPO Date2016-09-29
Employees1,313
CEOMing Hsieh
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS3596641098
CUSIP359664109
Income (Latest Year)
Revenue$322.67M
Gross Profit$130.88M
EBITDA$-45.83M
Operating Income$-91.1M
Net Income$-60.51M
EPS$-1.97
EPS Diluted$-1.97
Shares Outstanding$30.78M
Balance Sheet (Latest Year)
Total Assets$1.21B
Current Assets$550.49M
Cash & ST Investments$336.08M
Total Liabilities$106.81M
Total Debt$476K
Net Debt$-49.72M
Total Equity$1.11B
Debt / Equity0.00
Valuation Ratios
P/E Ratio-8.2
P/S Ratio1.57
P/B Ratio0.46
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message